The second and final installment of our discussion focuses on the use of stem cells and what further research is on the horizons for multiple sclerosis.
In the first installment of this discussion, our experts discuss the mechanisms, therapies and challenges involved in multiple sclerosis research.
We bring together Parkinson’s advances from across research and industry from the year so far.
Genetics are a risk factor for developing dementia due to Alzheimer’s disease and now several Alzheimer’s prevention trials are focused on individuals, who based on their age and genetic profile, are at high risk for developing the disease.
From novel biomarkers, to the potential use of the Zika virus as a tumor treatment, read our round-up of the biggest neuro-oncology news from the last year as we mark World Cancer Day.
A recent re-evaluation study reported that soluble APP-α and APP-β in CSF are strongly correlated with phosphorylated tau and are potentially useful biomarkers for earlier diagnosis of dementia disorders.